What is Dopaco?
Dopaco, Inc. operates as a specialized entity focused on the development and manufacturing of innovative medical device solutions. The company distinguishes itself through a rigorous commitment to patient safety and clinical efficacy, ensuring that all product lines adhere to stringent FDA and ISO quality standards. Beyond its core manufacturing competencies, the firm provides essential medical publication services, acting as a critical partner for healthcare organizations and clinical professionals. By bridging the gap between complex engineering and regulatory compliance, Dopaco maintains a competitive edge in the medical device supply chain, facilitating advancements in patient care through reliable, high-quality instrumentation.
How much funding has Dopaco raised?
Dopaco has raised a total of $724K across 2 funding rounds:
Debt
$350K
Debt
$374K
Debt (2020): $350K with participation from PPP
Debt (2021): $374K led by PPP
Key Investors in Dopaco
PPP
Public-Private Partnership
What's next for Dopaco?
With this recent capital deployment, Dopaco is poised to scale its contract manufacturing infrastructure to meet increasing global demand for specialized medical hardware. The strategic focus will likely shift toward optimizing production efficiencies and deepening its integration within the healthcare ecosystem. As the company navigates the complexities of the medical device market, this financial backing provides the necessary liquidity to pursue long-term research and development initiatives, ensuring that the firm remains at the forefront of technological innovation while maintaining its reputation for uncompromising quality and regulatory excellence.
See full Dopaco company page
